-
301por Prakash, Palanisamy, Kumari, Nisha, Gayathiri, Ekambaram, Selvam, Kuppusamy, Ragunathan, Manikavali Gurunadhan, Chandrasekaran, Murugesan, Al-Dosary, Munirah Abdullah, Hatamleh, Ashraf Atef, Nadda, Ashok Kumar, Kumar, Manu“…Due to their potent therapeutic and preventive actions, these compounds receive a lot of attention from scientists, particularly pharmacologists. The pharmacological activities of the Azima tetracantha Lam. …”
Publicado 2021
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
302por Danjuma, Mohammed Ibn-Mas’ud, Almasri, Hussam, Alshokri, Shaikha, Khir, Fadi Khazahia, Elmalik, Ashraf, Battikh, Naim Ghazi, Abdallah, Ibtihal Mahmoud Hassan, Elshafei, Mohamed, Fatima, Haajra, Mohamed, Mouhand Faisal Hamad, Maghoub, Yahya, Hussain, Tanweer, Kamal, Ijaz, Anwer, Zubair, Bidmos, Mubarak Ariyo, Elzouki, Abdel-Naser“…DILI outcomes were adjudicated by the updated Roussel Uclaf Causality Assessment Method (RUCAM). Two clinical pharmacologists and two general physicians utilized the Liverpool adverse drug reactions avoidability tool (LAAT) and the modified Hallas tools to rate the preventability of DILI-drug pairs. …”
Publicado 2020
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
303“…Interdisciplinary collaborations, including non-clinical pharmacologists, will be key to achieve such an ambitious program.…”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto -
304“…The Center is creating a public database to help researchers (primarly pharmacologists and medicinal chemists) to share and access data, results, and methods from PK-NPDI studies. …”
Enlace del recurso
Enlace del recurso
Enlace del recurso
Online Artículo Texto